is tirzepatide being discontinued Semaglutide and #tirzepatide have improved #obesity treatment but necessitate careful dosing and lifestyle adjustments to manage gastrointestinal side effects and ensure sustainable weight loss. https://ja.ma/466v73R FDA confirms tirzepatide shortage is

GIP-overexpressing mice demonstrate reduced diet-induced obesity and steatosis, and improved glucose homeostasis (PLoS ONE)

All subjects tolerated intermittent fasting well without any complications

This medication potently inhibits the URAT1 transporter to a lesser extent, which also affects ABCG2, OAT1, and OAT3

Effect of the dual glucosedependent insulinotropic peptide/gulcagonlike peptide 1 receptor agonist tirzepatide on lipid profile and waist circumference: A systematic review and metaanalysis

Triple-receptor engagement may shift fuel utilization and fat-oxidation patterns under high-calorie or obesogenic diets